Literature DB >> 15331183

Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis.

Ganesh Raghu1, Kevin K Brown.   

Abstract

This article discusses the importance and essentials of clinical evaluation and keys to an accurate diagnosis of interstitial lung disease.

Entities:  

Mesh：

Year:  2004        PMID： 15331183     DOI： 10.1016/j.ccm.2004.05.007

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  10 in total

1.  73-year-old woman with progressive shortness of breath.

Authors:  John E Moss; Michael J Maniaci; Margaret M Johnson
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

2.  The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease.

Authors:  Daniere Yurie Vieira Tomotani; Antônio Tonete Bafi; Eduardo Souza Pacheco; Tainá Veras de Sandes-Freitas; Laila Almeida Viana; Edgar Porto de Oliveira Pontes; Nikkei Tamura; Hélio Tedesco-Silva; Flavia Ribeiro Machado; Flávio Geraldo Rezende Freitas
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

3.  Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.

Authors:  Eric B Meltzer; William T Barry; Thomas A D'Amico; Robert D Davis; Shu S Lin; Mark W Onaitis; Lake D Morrison; Thomas A Sporn; Mark P Steele; Paul W Noble
Journal:  BMC Med Genomics       Date:  2011-10-05       Impact factor: 3.063

Review 4.  Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies.

Authors:  James D Finklea; Ruth E Grossmann; Vin Tangpricha
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

5.  Successful treatment with idarucizumab for diffuse alveolar hemorrhage induced by dabigatran etexilate: a case report.

Authors:  Akihiro Shiroshita; Kei Nakashima; Yu Tanaka; Akiko Tateishi; Masahiro Nemoto; Masahiro Aoshima
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

6.  The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.

Authors:  Mathew Suji Eapen; Archana Vijay Gaikwad; Isobel E Thompson; Wenying Lu; Stephen Myers; Pawan Sharma; Sukhwinder Singh Sohal
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Case-based discussion: Lymphocytic interstitial pneumonia a rare presentation in an immunocompetent adult male.

Authors:  Ajay Chitnis; Pradeep Kumar Vyas; Priyanka Chaudhary; Gaurav Ghatavat
Journal:  Lung India       Date:  2015 Sep-Oct

8.  Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties.

Authors:  Barbara Orzechowska; Kamil Awsiuk; Dawid Wnuk; Joanna Pabijan; Tomasz Stachura; Jerzy Soja; Krzysztof Sładek; Joanna Raczkowska
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

9.  A case of sine scleroderma with parenchymal lung disease.

Authors:  Mansoor Karimifar; Hourosadat Hashemi; Mozhgan Karimifar; Amir Kazizadeh
Journal:  Adv Biomed Res       Date:  2014-01-24

10.  ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs).

Authors:  Smriti Mishra; Mohammad I Shah; Malay Sarkar; Nimisha Asati; Chittaranjan Rout
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.